GENEVA, March 24 -- MOONLIGHT BIO, INC. (1616 Eastlake Ave. E.Alexandria LaunchLabs Suite 208Seattle, Washington 98102) filed a patent application (PCT/IB2025/059211) for "ENGINEERED CELLS COMPRISING A DLL3 BINDING RECEPTOR OR A P53 R175H BINDING RECEPTOR" on Sep 13, 2025. With publication no. WO/2026/058219, the details related to the patent application was published on Mar 19, 2026.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): INIGUEZ, Amanda Balboni (c/o Moonlight Bio, Inc.1616 Eastlake Ave. E.Alexandria LaunchLabs Suite 208Seattle, Washington 98102), BERGER, Mason Philip (c/o Moonlight Bio,...